Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Operating activities
Net Income (Loss)	$ 3,830	$ 77,141	$ 19,300	$ 83,234
Adjustments to reconcile net income to net cash provided by operating activities:
Loss (gain) on asset disposals			24	(1,145)
Depreciation of fixed assets	985	909	2,738	3,042
Amortization of internal-use software and intangibles	1,622	343	2,777	1,120
Deferred income taxes			(980)	(66,506)
Share-based compensation	4,218	3,638	12,656	9,489
Changes in operating assets and liabilities			(8,539)	(10,855)
Net cash provided by operating activities			27,976	18,379
Investing activities
Cash paid for business combination, net of cash acquired			(144,945)	0
Capital expenditures			(2,082)	(7,658)
Additional investments in corporate-owned life insurance policies			(27)	(2)
Net cash used in investing activities			(147,054)	(7,660)
Financing activities
Payment of preferred stock dividends			0	(1,663)
Debt proceeds, net of issuance costs			49,646	0
Debt repayments			(12,000)	0
Proceeds from Employee Stock Purchase Plan purchases			453	0
Repurchase of common shares to satisfy employee tax withholding			(2,848)	(5,734)
Principal payments under long-term obligations			0	(2)
Net cash provided by (used in) financing activities			35,251	(7,399)
Effect of exchange rate changes on cash			(303)	38
Net (decrease) increase in cash and cash equivalents			(84,130)	3,358
Cash and cash equivalents at beginning of period			144,891	112,842
Cash and cash equivalents at end of period	$ 60,761	$ 116,200	$ 60,761	$ 116,200